Six years after the first Society guidelines were published, cryptococcal meningitis (CM) remains an important cause of morbidity and mortality among HIV-infected adults in South Africa. Several important developments have spurred the publication of updated guidelines to manage this common fungal opportunistic infection. Recommendations described here include: (1) screening and pre-emptive treatment; (2) laboratory diagnosis and monitoring; (3) management of a first episode of CM; (4) amphotericin B deoxycholate toxicity prevention, monitoring and management; (5) timing of antiretroviral therapy among patients with CM; (6) management of raised intracranial pressure; (7) management of relapse episodes of CM.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Govender, N. P., Meintjes, G., Bicanic, T., Dawood, H., Harrison, T. S., Jarvis, J. N., … Scriven, J. (2013). Guideline for the prevention, diagnosis and management of cryptococcal meningitis among HIV-infected persons: 2013 update. In Southern African Journal of HIV Medicine (Vol. 14, pp. 76–86). AOSIS (pty) Ltd. https://doi.org/10.7196/SAJHIVMED.930